SUBSCRIBE

Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

Read more breaking news

 

 

Japanese-Swedish supplier ‘disappointed’ by ‘unexpected’ EFSA astaxanthin verdict

By Shane Starling+

25-Jul-2014
Last updated on 25-Jul-2014 at 15:52 GMT2014-07-25T15:52:09Z

AstaReal: “There are obvious limitations in treating all astaxanthin as equal, as it has been established that synthetic astaxanthin has a completely different composition compared to algal astaxanthin.”

AstaReal: “There are obvious limitations in treating all astaxanthin as equal, as it has been established that synthetic astaxanthin has a completely different composition compared to algal astaxanthin.”

Fuji Chemical-owned astaxanthin specialist AstaReal has emphasised differences in the types of the carotenoid not accounted for in a recent EFSA refusal to back intakes at 4 mg a day in the European Union.

The company said it was “disappointed” by the “unexpected” opinion by the European Food Safety Authority (EFSA), covered here , that was a response to its EU novel foods application.

But it said the opinion that handed in an acceptable daily intake (ADI) of 0.034 mg/kg bw or equivalent to 2 mg/day exposure for a 60 kg human, was just a, “speed bump on the road for natural algal astaxanthin appearing in healthy functional food products.”

“This decision comes unexpectedly when there is a wealth of safety data and historical use of natural algal astaxanthin in Europe and rest of the world,” said Swedish-based AstaReal president Dr Arun Nair, noting the firm would provide EFSA with, “relevant additional data”.

“Sufficiently different”

Dr Nair added: “The safety concerns raised by the EFSA panel stems from a study where rats were exposed to over 200mg synthetic astaxanthin feed formulation/kg bw/day. No such observations were made in a similar mice and dog studies.

The NDA report also pointed out that the human studies provided had addressed safety endpoints that showed no adverse effects after consumption of algal astaxanthin at doses ranging from 2 to 40 mg/day for 10 days to 3 months. This is also backed by a large portfolio of sub-chronic, in-vitro and in-vivo safety data.

Furthermore, the panel concluded that algal astaxanthin poses no risk with regard to increased lung cancer in smokers. This is because algal astaxanthin is sufficiently different in structure, metabolism and function in contrast to beta-carotene so it does not behave similarly. The panel also raised no concerns for genotoxicity.

“There are obvious limitations in treating all astaxanthin as equal, as it has been established that synthetic astaxanthin has a completely different composition compared to algal astaxanthin.”

AstaReal sought to use its algae-sourced astaxanthin in various forms in, fermented liquid dairy products, non-fermented liquid dairy products, fermented soya products and fruit drinks for healthy adults.

It proposed a level of 1.6 mg astaxanthin per 100 g or 100 mL of food or drink.

Research has linked astaxanthin with skin and eye health, immune function, healthy tendons, anti-aging, energy and heart benefits.

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Fytexia
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Indena
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Capsugel
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Ingredion
Balancing Innovation and Risk in Sports Nutrition Ingredients
NSF-International
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Roquette
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars